The 2016 US Preventive Services Task Force evidence report on colorectal cancer screening initially concluded that no methods of screening reduced the risk of all-cause mortality among these patients....
In a recent phase II trial, researchers further investigated the potential long-term benefits of aggressive local treatment in patients with unresectable colorectal liver metastases.
The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...
In their Practical Updates in Primary Care session, Jeanne M. Ferrante, MD, MPH, and Nell Maloney Patel, MD, FACS, FASCRS, discussed evidence-based cancer screening updates for primary care, with emphasis...
Physicians reviewing patient-facing screening guidance from major cancer centers may encounter recommendations that do not fully align with USPSTF standards. In a cross-sectional analysis, investigators...
